Delaware Health News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware Health News Online.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on February 17, 2026

Feb. 17, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 17, 2026

Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging

GlobeNewswire

Feb. 17, 2026

SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026

GlobeNewswire

Feb. 17, 2026

Precision Optics Reports Second Quarter Fiscal Year 2026 Financial Results

GlobeNewswire

Feb. 17, 2026

Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026

GlobeNewswire

Feb. 17, 2026

PetVivo Reports Results for Third Quarter and First Nine Months of Fiscal 2026

GlobeNewswire

Feb. 17, 2026

Voting Rights and Shares Capital of the Company

GlobeNewswire

Feb. 17, 2026

Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock

GlobeNewswire

Feb. 17, 2026

BrightSpring Health Services, Inc. to Host Investor Day on March 17, 2026

GlobeNewswire

Feb. 17, 2026

Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026

GlobeNewswire

Feb. 17, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 17, 2026

NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer

GlobeNewswire

Feb. 17, 2026

Portsmouth Square, Inc. Reports Second Quarter Fiscal 2026 Results; Hotel Performance Improves Year-Over-Year as Market Stabilization Continues

GlobeNewswire

Feb. 17, 2026

HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics

GlobeNewswire

Feb. 17, 2026

Fortrea erweitert Führungsteam und ernennt Oren Cohen zum Chief Medical Officer und Scott Dove zum President of Clinical Pharmacology Services

GlobeNewswire

Feb. 17, 2026

Fortrea amplía su equipo ejecutivo y nombra a Oren Cohen como Director Médico y a Scott Dove como Presidente de Servicios de Farmacología Clínica

GlobeNewswire

Feb. 17, 2026

Fortrea, 경영진 확대 발표하며 오렌 코헨 (Oren Cohen) 최고 의료 책임자 선임 및 스콧 도브 (Scott Dove) 임상약리 서비스 사장 임명

GlobeNewswire

Feb. 17, 2026

Fortrea 扩充高管团队，任命 Oren Cohen 为首席医疗官，Scott Dove 为临床药理服务总裁

GlobeNewswire

Feb. 17, 2026

Press release: Filing of the 2025 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report

GlobeNewswire

Feb. 17, 2026

Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel, et du « Form 20-F » américain

GlobeNewswire